European Leukemia Trial Registry
Trial: MDS Exjade

More Details
Title Exjade(ICL670) in transfusion dependent iron overload
Scientific Title A one-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral ICL670 (20 mg/kg/day) in patients diagnosed with transfusiondependent iron overload
Short Title MDS Exjade
Trialgroup NN
Type of Trial open-labeled, multicentric, singlegroup
Disease Myelodysplastic Syndrome(MDS) All subtypes
Age Other >=2 yrs
Status Active
Start of Recruitment 14.03.2005
Leader de Witte, Prof. Dr. med., Theo J.M.
Contactperson

principal investigator
de Witte, Prof. Dr. med., Theo J.M.
Email: leukemianet@hemat.umcn.nl; l.brinkman@hemat.umcn.nl

Shortprotocol Shortprotocol
created 30.08.2006 Student Studiendatenbank
changed 31.10.2008 5 Roswitha Kotthoff
© 2006 ELIC European Leukemia Information Center (Dr. N. Gökbuget, Dr. S. Schäfer) | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org